26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

304<br />

Chapter | 10 Hemostasis<br />

2. Components <strong>of</strong> the Fibrinolytic System<br />

a. Plasminogen<br />

Plasminogen is secreted by the liver as a single-chain 92-<br />

kDa glycoprotein with glutamine as the N-terminal amino<br />

acid (Glu-plasminogen). It is composed <strong>of</strong> five kringle-like<br />

domains containing “ lysine-binding sites ” and a C-terminal<br />

domain homologous to other trypsin-like proteases<br />

( Ponting et al ., 1992 ). The kringle domains mediate the<br />

interaction <strong>of</strong> plasminogen, and its active form plasmin,<br />

with substrates, inhibitors, and cell membranes.<br />

Consequently the kringle domains are important in both<br />

regulation <strong>of</strong> plasminogen activation and the localization<br />

<strong>of</strong> the proteolytic activity <strong>of</strong> plasmin to the appropriate<br />

physiological site ( Wu et al ., 1990 ). Plasminogen can be<br />

cleaved by plasmin at several sites resulting in lysine as the<br />

N-terminal amino acid (Lys-plasminogen) and the release<br />

<strong>of</strong> an 8-kDa N-terminal polypeptide. Lys-plasminogen, in<br />

the absence <strong>of</strong> fibrin, is converted to plasmin at a faster rate<br />

than Glu-plasminogen. The cleavage <strong>of</strong> an Arg-Val peptide<br />

bond in single-chain plasminogen converts it to plasmin,<br />

which now consists <strong>of</strong> two polypeptide chains linked<br />

by a disulfide bond ( Dobrovolsky and Titaeva, 2002 ). The<br />

N-terminal heavy A chain contains the kringle domains<br />

that convey substrate specificity to plasmin, whereas the<br />

C-terminal light B chain contains the catalytic site.<br />

b. Plasminogen Activators<br />

tPA is synthesized and secreted by endothelial cells as a<br />

70-kDa single-chain active enzyme. It is the only protease<br />

<strong>of</strong> the hemostatic system secreted in an active form<br />

( Dobrovolsky and Titaeva, 2002 ). The molecule is composed<br />

<strong>of</strong> five domains: the N-terminal domain, which is<br />

homologous to the finger-like domains <strong>of</strong> fibronectin, is<br />

followed by a region homologous to the epidermal growth<br />

factor (EGF) domain, two kringle-like domains similar to<br />

those <strong>of</strong> plasminogen, and a C-terminal domain homologous<br />

to other trypsin-like proteases ( van Zonneveld et al .,<br />

1986 ). The finger-like kringle domains possess two distinct<br />

fibrin-binding sites. Plasmin, kallikrein, and FXa can<br />

all cleave tPA to form a two-chain form <strong>of</strong> the molecule<br />

that, in the presence <strong>of</strong> fibrin, activates plasminogen at the<br />

same rate as single-chain tPA (Dobrovolsky and Titaeva,<br />

2002). Stimuli such as exercise, venous occlusion, and<br />

intravenous injection <strong>of</strong> vasoactive drugs can increase the<br />

release <strong>of</strong> tPA from endothelial cells, whereas inflammatory<br />

mediators such as tissue necrosis factor α (TNF α ) and<br />

interleukin-1 (IL-1) cause a decrease in free plasma tPA<br />

levels. Recombinant tPA is currently being used to induce<br />

thrombolysis in human patients with myocardial infarctions<br />

and other thromboembolic problems (Dobrovolsky<br />

and Titaeva, 2002).<br />

A trypsin-like protease capable <strong>of</strong> activating plasminogen<br />

was originally isolated from human urine and named<br />

urokinase. It is now known that many cell types can synthesize<br />

and secrete a single-chain 54-kDa glycoprotein, which<br />

was initially referred to as prourokinase. Current nomenclature<br />

designate these proteins as two forms: single-chain urokinase-type<br />

plasminogen activator (scuPA) and two-chain<br />

urokinase-type plasminogen activator (tcuPA). The scuPA<br />

molecule is composed <strong>of</strong> three domains. The N-terminal<br />

domain is homologous to the EGF domain, the middle protein<br />

is homologous to the kringle domain <strong>of</strong> plasminogen,<br />

and the C-terminal domain is homologous to trypsin-like<br />

proteases (Dobrovolsky and Titaeva, 2002). Both plasmin<br />

and kallikrein can cleave a Lys-Lys peptide bond in uPA to<br />

form fully functional tcuPA. Thrombin cleaves an Arg-Phe<br />

bond to produce a variant tcuPA molecule that appears incapable<br />

<strong>of</strong> directly activating plasminogen until after it has<br />

been further hydrolyzed by plasmin cleavage <strong>of</strong> a Lys-Ile<br />

bond (Dobrovolsky and Titaeva, 2002). Although initially<br />

considered to be a major component <strong>of</strong> the plasma fibrinolytic<br />

system, it is now recognized that a more important<br />

physiological function <strong>of</strong> uPA may be its ability to activate<br />

metalloproteinases that degrade cellular matrix components<br />

inducing pericellular proteolysis ( Lijnen, 2002 ). uPA mediates<br />

this effect through its ability to bind to specific cellular<br />

receptors (uPARs), which bring uPA into close contact with<br />

cell-bound plasminogen and thus promote plasmin generation<br />

on the cell surface. Thus, uPAR plays an important<br />

role in cell migration and the tissue remodeling processes<br />

that are required following vascular damage and thrombus<br />

formation.<br />

3. Mechanism <strong>of</strong> Fibrinolysis<br />

Fibrinolysis, like coagulation, is organized on a surface<br />

that facilitates the assembly and

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!